If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

St. Louis-based diabetes treatment startup Aegis Digital Health is nearing $1 million in its latest funding round and seeing ...

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...

DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today ...

Implementation of continuous glucose monitoring (CGM ... The researchers also administered a System Usability Scale questionnaire to nurses who engaged with the CGM policy, whereas patients ...

Dexcom unveiled its Dexcom G7 continuous glucose monitoring (CGM) for people with diabetes age two years and older in ...